Β-catenin overexpression in the mouse brain phenocopies lithium-sensitive behaviors

Neuropsychopharmacology

Volumn 32, Issue 10, 2007, Pages 2173-2183

  Gould, Todd D ^a   Einat, Haim ^a,b   O'Donnell, Kelley C ^a   Picchini, Alyssa M ^a,c   Schloesser, Robert J ^a   Manji, Husseini K ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Columbia College of Physicians and Surgeons ^*  (United States)

Author keywords

Animal model; Depression; Hyperactivity; Lithium; Mania; Wnt pathway

Indexed keywords

BETA CATENIN; DEXAMPHETAMINE; GLYCOGEN SYNTHASE KINASE 3; LITHIUM;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR CHANGE; BRAIN; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ENZYME INHIBITION; FORCED SWIMMING TEST; GENE OVEREXPRESSION; LOCOMOTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; ANTIMANIC AGENTS; BEHAVIOR, ANIMAL; BETA CATENIN; BRAIN; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; GLYCOGEN SYNTHASE KINASE 3; LITHIUM; MICE; MICE, TRANSGENIC; MOOD DISORDERS; PHENOTYPE; PSYCHOMOTOR AGITATION; UP-REGULATION;

EID: 34548684164     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301338     Document Type: Article

References (56)

1. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R (1997). Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 16: 3797-3804.
2. Beaulieu JM, Sotnikova TD, Yao WD, Kockeritz L, Woodgett JR, Gainetdinov RR et al (2004). Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc Natl Acad Sci USA 101: 5099-5104.
3. Behrens J, Jerchow BA, Wurtele M, Grimm J, Asbrand C, Wirtz R et al (1998). Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 280: 596-599.
4. Benedetti F, Serretti A, Pontiggia A, Bernasconi A, Lorenzi C, Colombo C et al (2005). Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-beta-50 T/C SNP. Neurosci Lett 376: 51-55.
5. Borchelt DR, Davis J, Fischer M, Lee MK, Slunt HH, Ratovitsky T et al (1996). A vector for expressing foreign genes in the brains and hearts of transgenic mice. Genet Anal 13: 159-163.
6. Bradford MM. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
7. Cappuccio I, Calderone A, Busceti CL, Biagioni F, Pontarelli F, Bruno V et al (2005). Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is required for the development of ischemic neuronal death. J Neurosci 25: 2647-2657.
8. Chenn A, Walsh CA (2002). Regulation of cerebral cortical size by control of cell cycle exit in neural precursors. Science 297: 365-369.
9. Cohen P, Goedert M (2004). GSK3 inhibitors: development and therapeutic potential. Nat Rev Drug Discov 3: 479-487.
10. Cox C, Harrison-Read PE, Steinberg H, Tomkiewicz M (1971). Lithium attenuates drug-induced hyperactivity in rats. Nature 232: 336-338.
11. Crawley JN (2000). What's Wrong with My Mouse?: Behavioral Phenotyping of Transgenic and Knockout Mice. Wiley-Liss: New York. xiii, 329pp.
12. Davies C, Sanger DJ, Steinberg H, Tomkiewicz M, U'Prichard DC (1974). Lithium and alpha-methyl-p-tyrosine prevent 'manic' activity in rodents. Psychopharmacologia 36: 263-274.
13. De Ferrari GV, Chacon MA, Barria MI, Garrido JL, Godoy JA, Olivares G et al (2003). Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils. Mol Psychiatry 8: 195-208.
14. Einat H, Yuan P, Gould TD, Li J, Du J, Zhang L et al (2003). The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J Neurosci 23: 7311-7316.
15. Fessler RG, Sturgeon RD, London SF, Meltzer HY (1982). Effects of lithium on behaviour induced by phencyclidine and amphetamine in rats. Psychopharmacology (Berlin) 78: 373-376.
16. Flemenbaum A (1977). Lithium inhibition of norepinephrine and dopamine receptors. Biol Psychiatry 12: 563-572.
17. Frances H, Marion MH, Simon P (1981). Antidepressant action of lithium: proposed mechanism based upon behavioral analysis in the mouse. Prog Neuropsychopharmacol 5: 357-361.
18. Furlong MT, Morin PJ (2000). Rare activation of the TCF/beta-catenin pathway in ovarian cancer. Gynecol Oncol 77: 97-104.
19. Gottesman II, Gould TD (2003). The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 160: 636-645.
20. Gould TD, Chen G, Manji HK (2004a). In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3. Neuropsychopharmacology 29: 32-38.
21. Gould TD, Einat H, Bhat R, Manji HK (2004b). AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test. Int J Neuropsychopharmacol 7: 387-390.
22. Gould TD, Gray NA, Manji HK (2003). Effects of a glycogen synthase kinase-3 inhibitor, lithium, in adenomatous polyposis coli mutant mice. Pharmacol Res 48: 49-53.
23. Gould TD, Manji HK (2005). Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs. Neuropsychopharmacology 30: 1223-1237.
24. Gould TD, O'Donnell KC, Picchini AM, Manji HK Strain difference in lithium attenuation of d-amphetamine hyperlocomotion: a mouse model for the genetics of lithium response. Neuropsychopharmacology [E-pub ahead of print].
25. Gould TD, Picchini AM, Einat H, Manji HK (2006). Targeting glycogen synthase kinase-3 in the CNS: implications for the development of new treatments for mood disorders. Curr Drug Targets 7: 1399-1409.
26. Gould TD, Quiroz JA, Singh J, Zarate CA, Manji HK (2004c). Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers. Mol Psychiatry 9: 734-755.
27. Hamburger-Bar R, Robert M, Newman M, Belmaker RH (1986). Interstrain correlation between behavioural effects of lithium and effects on cortical cyclic AMP. Pharmacol Biochem Behav 24: 9-13.
28. Hasler G, Drevets WC, Gould TD, Gottesman II, Manji HK (2006). Toward constructing an endophenotype strategy for bipolar disorders. Biol Psychiatry 60: 93-105.
29. Ilouz R, Kaidanovich O, Gurwitz D, Eldar-Finkelman H (2002). Inhibition of glycogen synthase kinase-3beta by bivalent zinc ions: insight into the insulin-mimetic action of zinc. Biochem Biophys Res Commun 295: 102-106.
30. Institute of Laboratory Animal Resources (US) (1996). Guide for the Care and Use of Laboratory Animals. National Academy Press: Washington, DC. xii, 125pp.
31. Kaidanovich-Beilin O, Milman A, Weizman A, Pick CG, Eldar-Finkelman H (2004). Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus. Biol Psychiatry 55: 781-784.
32. Kelley AE (2005). Measurement of rodent stereotyped behavior. In: Crawley JN, Gerfen CR, Rogawski MA, Sibley DR, Skolnick P, Wray S (eds). Current Protocols in Neuroscience. John Wiley & Sons: New York, NY. pp 8.8.1-8.8.13.
33. Klein PS, Melton DA (1996). A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 93: 8455-8459.
34. Kratz JE, Stearns D, Huso DL, Slunt HH, Price DL, Borchelt DR et al (2002). Expression of stabilized beta-catenin in differentiated neurons of transgenic mice does not result in tumor formation. BMC Cancer 2: 33.
35. Kroczka B, Branski P, Palucha A, Pilc A, Nowak G (2001). Antidepressant-like properties of zinc in rodent forced swim test. Brain Res Bull 55: 297-300.
36. Kroczka B, Zieba A, Dudek D, Pilc A, Nowak G (2000). Zinc exhibits an antidepressant-like effect in the forced swimming test in mice. Pol J Pharmacol 52: 403-406.
37. Kwok JB, Hallupp M, Loy CT, Chan DK, Woo J, Mellick GD et al (2005). GSK3B polymorphisms alter transcription and splicing in Parkinson's disease. Ann Neurol 58: 829-839.
38. Lie DC, Colamarino SA, Song HJ, Desire L, Mira H, Consiglio A et al (2005). Wnt signalling regulates adult hippocampal neurogenesis. Nature 437: 1370-1375.
39. Madsen TM, Newton SS, Eaton ME, Russell DS, Duman RS (2003). Chronic electroconvulsive seizure up-regulates beta-catenin expression in rat hippocampus: role in adult neurogenesis. Biol Psychiatry 54: 1006-1014.
40. Miyauchi T, Kikuchi K, Satoh S (1981). Further studies on the potentiating effect of lithium chloride on methamphetamine-induced stereotypy in mice. Jpn J Pharmacol 31: 61-68.
41. Naccarato WF, Ray RE, Wells WW (1974). Biosynthesis of myoinositol in rat mammary gland. Isolation and properties of the enzymes. Arch Biochem Biophys 164: 194-201.
42. Namima M, Sugihara K, Watanabe Y, Sasa H, Umekage T, Okamoto K (1999). Quantitative analysis of the effects of lithium on the reverse tolerance and the c-Fos expression induced by methamphetamine in mice. Brain Res Brain Res Protoc 4: 11-18.
43. Nowak G, Szewczyk B, Wieronska JM, Branski P, Palucha A, Pilc A et al (2003). Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats. Brain Res Bull 61: 159-164.
44. O'Brien WT, Harper AD, Jove F, Woodgett JR, Maretto S, Piccolo S et al (2004). Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium. J Neurosci 24: 6791-6798.
45. Orford K, Crockett C, Jensen JP, Weissman AM, Byers SW (1997). Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin. J Biol Chem 272: 24735-24738.
46. Ozawa H, Miyauchi T (1977). Potentiating effect of lithium chloride on methamphetamine-induced stereotypy in mice. Eur J Pharmacol 41: 213-216.
47. Peifer M, Pai LM, Casey M (1994). Phosphorylation of the Drosophila adherens junction protein Armadillo: roles for wingless signal and zeste-white 3 kinase. Dev Biol 166: 543-556.
48. Porsolt RD, Le Pichon M, Jalfre M (1977). Depression: a new animal model sensitive to antidepressant treatments. Nature 266: 730-732.
49. Post RM, Weiss SR, Pert A (1984). Differential effects of carbamazepine and lithium on sensitization and kindling. Prog Neuropsychopharmacol Biol Psychiatry 8: 425-434.
50. Ray Jr WJ, Szymanki ES, Ng L (1978). The binding of lithium and of anionic metabolites to phosphoglucomutase. Biochim Biophys Acta 522: 434-442.
51. Rubin EH, Wooten GF (1984). The behavioral and biochemical effects of lithium on dopaminergic agonist-induced supersensitivity. Psychopharmacology (Berlin) 84: 217-220.
52. Stambolic V, Ruel L, Woodgett JR (1996). Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol 6: 1664-1668.
53. Wielosz M (1976). The effect of lithium chloride on the activity of some psychotropic drugs. Pol J Pharmacol Pharm 28: 189-198.
54. Yang P, Singhal N, Modi G, Swann A, Dafny N (2001). Effects of lithium chloride on induction and expression of methylphenidate sensitization. Eur J Pharmacol 426: 65-72.
55. York JD, Ponder JW, Majerus PW (1995). Definition of a metal-dependent/ Li(+)-inhibited phosphomonoesterase protein family based upon a conserved three-dimensional core structure. Proc Natl Acad Sci USA 92: 5149-5153.
56. Yost C, Torres M, Miller JR, Huang E, Kimelman D, Moon RT (1996). The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes Dev 10: 1443-1454.